Time to stop operating on breast cancer patients with pathological complete response?-Reference-Cited by-同舟云学术

Time to stop operating on breast cancer patients with pathological complete response?

Published:2013-09 Issue:9 Volume:39 Page:924-930
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology (EJSO)
language:en
Short-container-title:European Journal of Surgical Oncology (EJSO)

Author:

Rea D.,Tomlins A.,Francis A.

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference44 articles.

1. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18;Wolmark;J Natl Cancer Inst Monogr,2001

2. Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial Aberdeen Breast Group;Heys;Clin Breast Cancer,2002

3. Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel;Smith;J Clin Oncol,2002

4. Neoadjuvant chemotherapy adapted by Interim response improves overall survival of primary breast cancer patients – results of the GeparTrio trial;von Minckwitz;Cancer Res,2011

5. International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010);Berruti;J Natl Cancer Inst Monogr,2011

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pirfenidone inhibits CCL2-mediated Treg chemotaxis induced by palbociclib and fulvestrant in HR+/HER2− breast cancer;International Immunopharmacology;2024-12

2. Assessment of Pathological Complete Response Using Vacuum-Assisted Biopsy in Breast Cancer Patients Who Have Clinical and Radiological Complete Response After Neo-Adjuvant Chemotherapy;Breast Cancer: Basic and Clinical Research;2023-01

3. Preliminary experiences of PET/MRI in predicting complete response in patients with breast cancer treated with neoadjuvant chemotherapy;Molecular and Clinical Oncology;2021-12-24

4. Avoiding breast cancer surgery in a select cohort of complete responders to neoadjuvant chemotherapy: The long-term outcomes;Annals of Medicine and Surgery;2021-06

5. A new method to optimize resection area using a radiation treatment planning system and deformable image registration for breast-conserving surgery after neoadjuvant chemotherapy;European Journal of Surgical Oncology;2021-04